CPEX Pharmaceuticals, Inc. 4
4 · CPEX Pharmaceuticals, Inc. · Filed Apr 7, 2011
Insider Transaction Report
Form 4
SPIEGEL JOHN W
Director
Transactions
- Disposition to Issuer
Common Stock
2011-04-05−1,500→ 0 total - Disposition to Issuer
Restricted Stock Unit
2011-04-05−5,600→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2011-04-05−3,000→ 0 totalExercise: $9.99Exp: 2012-06-21→ Common Stock (3,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-05−2,000→ 0 totalExercise: $9.01Exp: 2013-05-21→ Common Stock (2,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-05−2,000→ 0 totalExercise: $11.22Exp: 2014-06-07→ Common Stock (2,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-05−5,000→ 0 totalExercise: $17.20Exp: 2018-07-01→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-05−2,000→ 0 totalExercise: $9.68Exp: 2015-05-24→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger between CPEX Pharmaceuticals, Inc., FCB I Holdings Inc. and FCB I Acquisition Corp. dated January 3, 2011 (the "Merger Agreement"), each share of CPEX common stock was exchanged for $27.25 and each restricted stock unit was cancelled in exchange for a cash payment equal to the product of (i) $27.25 and (ii) the total number of shares underlying such restricted stock unit.
- [F2]This option is fully-vested
- [F3]Pursuant to the Merger Agreement, each CPEX stock option was converted into the right to receive an amount in cash equal to the product of $27.25 over the per share exercise price for such option and the total number of shares underlying such option.